NCT03090386View on ClinicalTrials.gov

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 25, 2017

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2020

Conditions
Brain Tumor
Interventions
OTHER

Cognitive Surveys

Complete the Cognitive Communication Survey, standardized cognitive and language assessments, and the Follow-up Cognitive Communication Survey after treatment

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03090386 - Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients | Biotech Hunter | Biotech Hunter